Documentary record · OUTBREAK R&D BRIEFING

WHO Member States briefing: three vaccines and three therapeutics reported in trials in the DRC Ebola response

CLINICAL INVESTIGATION UNDERWAY

Event date

September 1, 2026

Jurisdiction

Global

Issuing body

WHO

Action type

OUTBREAK R&D BRIEFING

Lifecycle state

CLINICAL INVESTIGATION UNDERWAY

Verification date

1 September 2026

None. A briefing on research activity; it authorises, approves and requires nothing.

What this establishes

  • WHO reports three vaccine candidates or approaches and three therapeutics in trials in the current response.
  • Trial infrastructure is operating during an active outbreak.

What this does not establish

  • Efficacy of any candidate.
  • Availability of any product outside a trial.
  • Any regulatory authorisation.

Why it matters

Research activity and product availability are different facts, and collapsing them is the most common error in outbreak reporting. The outbreak state map therefore carries outbreak state, PHEIC state, licensed countermeasure, off-label research use, vaccine trials, therapeutic trials and the WHO recommendation as seven separate dimensions, so a reader can never infer a product from a protocol.

Primary source

Register: data/events.json · record id who-drc-ebola-trials-2026-09-01.